CICA: Celiac, IBS, and Crohn's Full Array - ALCAT Test Kit
The CICA evaluates a patient’s genetic risk for celiac disease, serum markers associated with active celiac disease process, and genetic serum markers associated with Crohn’s disease, and serological markers for diminished antigen exclusion in the gut.
PLEASE NOTE: This is a pre-paid shipping kit that includes a blood draw. Within 3-5 days of your order, a member of ALCAT’s mobile draw team will contact you to schedule the blood draw appointment. A mobile lab technician will come to you for the blood draw so please do not visit your local lab.
CICA TEST COMPONENTS
More than 95% of patients with celiac disease possess HLA-DQ2.5 and/or HLA-DQ8 genotype. More than 90% of those with celiac have the DQ2.5 genotype. Absent these markers, development of celiac is highly unlikely.
Crohn’s disease is triggered by a variety of environmental and genetic factors. It is described as a chronic inflammatory bowel disease (IBD) caused by a dysregulation of the immune response to intestinal flora and in parallel, accompanied by a defect of the epithelial barrier.
The predominant genetic markers are:
- NOD2/CARD15 associated with the innate immune system and the activation of nuclear factor кB (NF- кB).
- T300A mutation in the ATG16L1 gene increases its susceptibility to degradation by Caspase 3 and thus is associated with autophagy.
Tissue transglutaminase antibody (tTG) – IgA & IgG
In active celiac disease, damaged enterocytes produce tTG, therefore antibodies against tTG (IgA and/or IgG) are indicative of an active disease process. In patients with normal total IgA levels and negative tTG antibodies, the diagnosis of active celiac disease is unlikely. However, a certain percentage of patients with celiac disease may be seronegative. If tTG IgA is negative, while celiac disease is suspected, then additional markers included in this panel become more relevant in the diagnosis of gluten-related disorders.
Deamidated gliadin peptide (DGP) antibody - IgA & IgG
Deamidated gliadin can bind with tTG and become immunogenic. Therefore, detecting the presence of elevated IgA and/or IgG antibodies against DGP is an additional indicator of an active celiac disease process.
Anti-Saccharomyces Cerevisiae Antibody (ASCA)
ASCA is an indicator for the presence of Crohn’s disease. The presence of ASCA may also reflect increased intestinal inflammation and permeability, including that associated with active celiac disease.
Total Serum IgA
It is common for celiac disease patients to be IgA deficient. It is the most common immunologic deficiency (1:400-1:700 in the general population and 1:50 in celiac disease patients) and may be the single largest contributor to false negative results in biopsy confirmed celiac disease patients. Total Serum IgA is used as a measurement to qualify IgA testing for tissue transglutaminase (tTG) and deaminated gliadin peptide (DGP) antibody levels. When IgA levels are low or deficient, it is important to check IgG levels for both tTG and DGP (included in this array).
Who Should Test?
- Those with gastrointestinal symptoms and autoimmune disorders that might suggest a problem with gluten
- Those with increased intestinal permeability which has been linked to autoimmune disorders and other conditions
- Those suspected to have Crohn’s or celiac disease
- Those suffering from symptoms of IBS including diarrhea, bloating or cramping
- Those with chronic fatigue
- Those with malabsorption of nutrients or iron deficiency
Trusted, Secure, & Confidential
Shop All Tests